[HTML][HTML] A narrative review of tumor-associated macrophages in lung cancer: regulation of macrophage polarization and therapeutic implications

SS Sedighzadeh, AP Khoshbin, S Razi… - … lung cancer research, 2021 - ncbi.nlm.nih.gov
Lung cancer is the deadliest malignancy worldwide. An inflammatory microenvironment is a
key factor contributing to lung tumor progression. Tumor-Associated Macrophages (TAMs) …

CXCL12/CXCR4 signal transduction in diseases and its molecular approaches in targeted-therapy

A Mousavi - Immunology Letters, 2020 - Elsevier
Chemokines are small molecules called “chemotactic cytokines” and regulate many
processes like leukocyte trafficking, homing of immune cells, maturation, cytoskeletal …

Nanomaterials targeting tumor associated macrophages for cancer immunotherapy

C Zhao, X Pang, Z Yang, S Wang, H Deng… - Journal of Controlled …, 2022 - Elsevier
Tumor-associated macrophages (TAMs) play an important role in regulating tumor growth,
invasion and metastasis, and constitute approximately 50% of tumor mass. TAMs can exist …

CXCR4 antagonist AMD3100 (plerixafor): From an impurity to a therapeutic agent

J Wang, BA Tannous, MC Poznansky, H Chen - Pharmacological research, 2020 - Elsevier
Abstract AMD3100 (plerixafor), a CXCR4 antagonist, has opened a variety of avenues for
potential therapeutic approaches in different refractory diseases. The CXCL12/CXCR4 axis …

Chemokines and NSCLC: Emerging role in prognosis, heterogeneity, and therapeutics

S Srivastava, A Mohanty, A Nam, S Singhal… - Seminars in cancer …, 2022 - Elsevier
Lung cancer persists to contribute to one-quarter of cancer-associated deaths. Among the
different histologies, non-small cell lung cancer (NSCLC) alone accounts for 85% of the …

Macrophages are a double-edged sword: molecular crosstalk between tumor-associated macrophages and cancer stem cells

S Luo, G Yang, P Ye, N Cao, X Chi, WH Yang, X Yan - Biomolecules, 2022 - mdpi.com
Cancer stem cells (CSCs) are a subset of highly tumorigenic cells in tumors. They have
enhanced self-renewal properties, are usually chemo-radioresistant, and can promote tumor …

A novel immune checkpoint siglec-15 antibody inhibits LUAD by modulating mφ polarization in TME

X Xiao, Y Peng, Z Wang, L Zhang, T Yang, Y Sun… - Pharmacological …, 2022 - Elsevier
Abstract Background Siglec-15 (S15) is a type-I transmembrane protein and is considered a
new candidate of immune checkpoint inhibitor for cancer immunotherapy. Methods In the …

Predictive and prognostic biomarkers for lung cancer bone metastasis and their therapeutic value

X Chai, E Yinwang, Z Wang, Z Wang, Y Xue, B Li… - Frontiers in …, 2021 - frontiersin.org
Lung cancer is the leading cause of cancer-related death worldwide. Bone metastasis,
which usually accompanies severe skeletal-related events, is the most common site for …

[HTML][HTML] Recent advancement in pyrrolidine moiety for the management of cancer: A review

R Sahu, K Shah, R Malviya, D Paliwal, S Sagar… - Results in …, 2024 - Elsevier
Globally, cancer is growing more prevalent and affects the great majority of people; as a
result, new anticancer medications are presently being developed, and their safety is …

Developing Nanoceria‐Based pH‐Dependent Cancer‐Directed Drug Delivery System for Retinoblastoma

R Gao, RN Mitra, M Zheng, K Wang… - Advanced functional …, 2018 - Wiley Online Library
Abstract Development of a single combinatorial nanoplatform technology to target cancer
cells has been an unprecedented reality in boosting synergistic antitumor activities and in …